Novavax Finally Gets the Green Light

Novavax just scored long-awaited FDA approval for its COVID-19 vaccine, and their stock shot up 15%! The catch? It’s only for folks 65+ or anyone 12+ with health risks. This is a big deal for people who wanted a non-mRNA option (think: not Pfizer or Moderna). Novavax is teaming up with Sanofi to roll it out this fall, but they’ll need more approvals for future updates. Big pharma drama, anyone? #Novavax #COVID19 #VaccineNews #FDA #HealthUpdates #Health